Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma Life Science Investing
Nextech3D.ai Accelerates Eventdex Integration; Expands AI Matchmaking and Achieves Milestone Production of 800 Interactive Floor Plans in 2025 Artificial Intelligence Investing
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 Pharmaceutical Investing
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 Life Science Investing
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum Medical Device Investing
Gilead Joins Partners for Delivery of First Shipments of Breakthrough Twice-yearly Lenacapavir for HIV Prevention to Sub-Saharan Africa Life Science Investing
Rakovina Therapeutics' President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit Life Science Investing
Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers Life Science Investing
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 Life Science Investing
NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position Life Science Investing
